Woman Man | 18 years and more
- | Country :
- France
- | organs :
- Sein
- | Specialty :
- Thérapies Ciblées
Extract
Phase II study for repeated dosing of the trifunctional bispecific anti-HER-2/neu x anti-CD3 antibody ertumaxomab in patients with HER-2/neu 1+ or 2+/FISH negative expressing advanced or metastatic breast cancer (stage IIIb/IV) progressing after endocrine treatment.
Scientific Abstract
en cours d'intégration;